Literature DB >> 11200369

Invasive group A streptococcal infections in Sweden in 1994 and 1995: epidemiology and clinical spectrum.

N Svensson1, S Oberg, B Henriques, S Holm, G Källenius, V Romanus, J Giesecke.   

Abstract

A nationwide study of invasive group A streptococcal (GAS) infections in Sweden during 1994-1995 was carried out. All Swedish microbiological laboratories were asked to report isolates of GAS from normally sterile sites. During the study period they were also asked to send their isolates for T typing. Questionnaires were sent to the physicians in charge of each patient. The incidence, serotype, clinical presentation, symptoms and outcome were recorded. Clinical data were obtained for 468 of 556 patients with GAS bacteraemia. The lethality rate was 16%, but was much higher (37%) in the 113 patients who developed streptococcal toxic shock syndrome (STSS). Streptococci of serotype T1 dominated during the study period and were linked to the increase in invasive GAS infections. They also carried an increased risk of causing STSS. Invasive streptococcal disease with STSS most often has an unknown primary focus or is associated with soft tissue infections. Invasive streptococcal disease not associated with STSS most often has a skin infection as portal of entry or else an unknown focus.

Entities:  

Mesh:

Year:  2000        PMID: 11200369     DOI: 10.1080/003655400459504

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  14 in total

1.  Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002).

Authors:  Gregory J Tyrrell; Marguerite Lovgren; Bertha Kress; Karen Grimsrud
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 2.  Toxic shock syndrome in children: epidemiology, pathogenesis, and management.

Authors:  Yu-Yu Chuang; Yhu-Chering Huang; Tzou-Yien Lin
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

3.  Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level.

Authors:  Katarzyna Szczypa; Ewa Sadowy; Radoslaw Izdebski; Lenka Strakova; Waleria Hryniewicz
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

4.  Dynamics of the immune response against extracellular products of group A streptococci during infection.

Authors:  Linda Maripuu; Anna Eriksson; Björn Eriksson; Karlis Pauksen; Stig Holm; Mari Norgren
Journal:  Clin Vaccine Immunol       Date:  2006-11-08

5.  The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection.

Authors:  Shigefumi Okamoto; Shigetada Kawabata; Yutaka Terao; Hideaki Fujitaka; Yoshinobu Okuno; Shigeyuki Hamada
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.

Authors:  Bogdan Luca-Harari; Kim Ekelund; Mark van der Linden; Margit Staum-Kaltoft; Anette M Hammerum; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

7.  Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003.

Authors:  Roger Meisal; E Arne Høiby; Ingeborg S Aaberge; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2008-04-16       Impact factor: 5.948

8.  Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice.

Authors:  Shigefumi Okamoto; Shigetada Kawabata; Ichiro Nakagawa; Yoshinobu Okuno; Toshiyuki Goto; Kouichi Sano; Shigeyuki Hamada
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe.

Authors:  Bogdan Luca-Harari; Jessica Darenberg; Shona Neal; Tuula Siljander; Lenka Strakova; Asha Tanna; Roberta Creti; Kim Ekelund; Maria Koliou; Panayotis T Tassios; Mark van der Linden; Monica Straut; Jaana Vuopio-Varkila; Anne Bouvet; Androulla Efstratiou; Claes Schalén; Birgitta Henriques-Normark; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

10.  Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004.

Authors:  Theresa L Lamagni; Shona Neal; Catherine Keshishian; Neelam Alhaddad; Robert George; Georgia Duckworth; Jaana Vuopio-Varkila; Androulla Efstratiou
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.